From COPD News of the Day:
This is meant to not have the stomach problems - reflux etc - that lots of our meds cause, and to have anti-inflammatory potential. Tolerated well in a week-long trial, so longer research is going on.
Imagine a life without pred - but its always hard to know if these new drugs end up being a wind-up. It's working name is RPL-554 so you can google and probably get more info - it was written up in the Lancet.
Its been trialled so far in UK (Kings i think) Italy and Netherlands.
Keep safe in the storm people.